Error-proofing in the production process of pharmaceuticals isn t just a matter of good business, it has life-and-death implications for consumers. To that end, the 2013 Drug Quality and Security Act in large part requires new mandates on tracking and tracing chain of custody in the supply chain. Pharmaceutical Supply Chain: Drug Quality and Security Act overviews the new mandate and its implications, including implementation strategies for track-and-trace programs along with presenting a fuller understanding of the mechanics of intergovernmental policies and oversights.
The...
Error-proofing in the production process of pharmaceuticals isn t just a matter of good business, it has life-and-death implications for consumers....
